KEGG: sce:YBR220C
STRING: 4932.YBR220C
YBR220C is a gene locus in Saccharomyces cerevisiae (baker's yeast), specifically from the reference genome sequence derived from laboratory strain S288C. It has gained research interest partly due to its involvement in certain phenotypes, including contribution to hygromycin B resistance when deleted . The protein encoded by this gene is studied within the broader context of yeast genetics and cell biology research, with information about its sequence, genomic context, and protein properties available through resources like the Saccharomyces Genome Database .
YBR220C Antibody (such as product CSB-PA336436XA01SVG) is a polyclonal antibody raised in rabbits using recombinant Saccharomyces cerevisiae (strain ATCC 204508/S288c) YBR220C protein as the immunogen. It's supplied in liquid form containing preservative (0.03% Proclin 300) and stabilizers (50% Glycerol, 0.01M PBS, pH 7.4). The antibody is purified using antigen affinity methods and is intended for research use only, not for diagnostic or therapeutic applications .
The YBR220C Antibody has been tested and validated for applications including Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blot (WB) for identification of the YBR220C antigen. These applications allow researchers to detect and quantify the presence of YBR220C protein in various experimental contexts .
Upon receipt, YBR220C Antibody should be stored at -20°C or -80°C. Repeated freeze-thaw cycles should be avoided to maintain antibody integrity and activity. The antibody is typically supplied in a storage buffer containing glycerol and preservatives to enhance stability during storage .
When designing experiments with YBR220C Antibody, include both positive and negative controls. For Western Blot applications, a positive control might include lysate from wild-type S. cerevisiae strain S288c, while a negative control could be a YBR220C deletion strain. Similar to other antibody validation approaches, comparing signal between samples with and without the target protein is essential for confirming specificity .
To validate antibody specificity, employ multiple approaches:
Comparative testing: Test antibody against wild-type yeast and YBR220C knockout strains
Cross-reactivity assessment: Verify the antibody doesn't cross-react with related proteins
Blockers and competitors: Use purified YBR220C protein to demonstrate competitive binding
Multiple techniques confirmation: Validate results across different methodologies (WB, ELISA)
This multi-faceted approach is consistent with standard practices in the field for validating antibody specificity, similar to validation methods used for other antibodies .
Research has shown that deletions of YBR220C contribute to hygromycin B resistance phenotypes in yeast . To investigate this connection, researchers can:
Generate YBR220C knockout strains and confirm the deletion using YBR220C Antibody in Western Blot
Compare protein expression levels in wild-type and resistant strains using quantitative immunoblotting
Perform protein localization studies under hygromycin B treatment conditions
Investigate protein-protein interactions that may change during stress response using co-immunoprecipitation with YBR220C Antibody
These approaches can help elucidate the molecular mechanisms behind the observed resistance phenotype .
Synthetic Chromosome Rearrangement and Modification by LoxP-mediated Evolution (SCRaMbLE) experiments have identified YBR220C as contributing to hygromycin B resistance when deleted . YBR220C Antibody can complement these studies by:
Confirming protein absence in deletion strains generated through SCRaMbLE
Quantifying protein levels in partial deletion or modification events
Examining protein localization changes in rearranged genomes
Investigating potential compensatory protein expression changes in response to YBR220C modification
This integration of protein-level analysis with genomic studies provides a more comprehensive understanding of phenotypic changes observed in SCRaMbLE experiments .
When using YBR220C Antibody in Western Blot applications, researchers may encounter several common issues:
| Issue | Possible Causes | Recommended Solutions |
|---|---|---|
| No signal | Insufficient protein, degraded antibody, incorrect dilution | Increase protein loading, verify antibody activity with control, optimize antibody dilution |
| High background | Non-specific binding, insufficient blocking, contaminated buffers | Increase blocking time/concentration, optimize antibody dilution, prepare fresh buffers |
| Multiple bands | Cross-reactivity, protein degradation, post-translational modifications | Verify sample preparation, add protease inhibitors, perform peptide competition assay |
| Inconsistent results | Variable protein extraction efficiency, inconsistent transfer | Standardize lysate preparation, validate transfer efficiency with total protein stain |
These troubleshooting approaches follow standard practices for optimizing antibody-based detection methods .
When facing contradictions between antibody-based protein detection and genetic data:
Verify antibody specificity using knockout controls to confirm the antibody is truly detecting YBR220C
Consider post-transcriptional regulation that might explain differences between gene and protein levels
Examine experimental conditions that might affect protein stability or modification state
Validate results with orthogonal methods such as mass spectrometry or alternative antibodies
Review genetic modification verification to confirm gene deletions or modifications are as expected
This systematic approach can help reconcile apparently contradictory results and potentially reveal interesting biological regulatory mechanisms .
When adapting YBR220C Antibody for immunofluorescence applications:
Fixation optimization: Different fixation methods (paraformaldehyde vs. methanol) may affect epitope accessibility
Permeabilization conditions: Yeast cell wall may require specialized permeabilization protocols
Antibody concentration: Typically requires higher concentrations than for Western Blot
Appropriate controls: Include both secondary antibody-only controls and YBR220C deletion strains
Counterstaining: Use DAPI for nuclear visualization and cell wall stains for yeast cell morphology
These approaches are similar to those demonstrated for other antibodies in cellular imaging studies, such as those shown for Insulin R/CD220 in human cell lines .
If YBR220C is suspected to have RNA-binding properties, researchers can adapt RNA immunoprecipitation (RIP) protocols:
Form antigen-antibody complexes by incubating yeast cell lysate with YBR220C Antibody
Capture complexes using appropriate secondary antibody-conjugated magnetic beads
Extensively wash complexes to remove non-specific interactions
Elute and analyze associated RNAs through sequencing or RT-PCR
This approach mirrors established RIP protocols used for other RNA-binding proteins, with appropriate modifications for yeast cells and YBR220C-specific optimizations .
While YBR220C Antibody is primarily validated for ELISA and Western Blot , adapting it for flow cytometry would require:
Cell preparation: Specialized protocols for yeast cell wall digestion and permeabilization
Antibody titration: Determining optimal concentration through dilution series
Appropriate controls: Including unstained cells, secondary-only controls, and YBR220C deletion strains
Fluorophore selection: Choosing compatible fluorophores with minimal spectral overlap with yeast autofluorescence
Gating strategy: Developing appropriate gating to distinguish positive from negative populations
These considerations follow standard flow cytometry practices, similar to those demonstrated for other antibodies like Insulin R/CD220 .